Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Risk for adverse outcomes in asthma: Assess to impress!

Lilia Maia Santos, Cláudia Chaves Loureiro
European Respiratory Journal 2016 48: PA4169; DOI: 10.1183/13993003.congress-2016.PA4169
Lilia Maia Santos
1Pneumology Unit, Hospitais da Universidade de Coimbra, Coimbra, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cláudia Chaves Loureiro
2Centre of Pneumology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Background: Asthma is a heterogeneous disease with different severity degrees and several modifiable risk factors that might place the patient at risk for exacerbations. Their adequate management is crucial to achieve disease control. When indicated, the referral to expert advice should be considered.

Aim: Analyze the characteristics of exacerbated asthmatics, namely their risk factors for adverse outcomes, disease severity and strategies for follow-up.

Methods: Retrospective study of asthmatic patients admitted for acute exacerbations in a Pneumology ward of a central university hospital during 2014. GINA 2015 criteria were used to assess disease control.

Results: Most of the 83 admissions were due to infectious exacerbations, with a peak during the winter months, and 67.2% of those had no influenza or pneumococcal vaccination. Median age was 56 years (IR=35), mostly female (72.3%). Comorbidities like overweight (68.6%) and smoking history with COPD overlap (25%) were most noticed. At least one risk factor was present in 89.2% and a significant number (18.1%) had no medical management or chronic medication. From the 24.1% of patients managed in primary care, two thirds were on Step 3 or 4 GINA treatment and had at least one criteria for expert referral. Only a small percentage had a written action plan.

Conclusions: The most noticed comorbidities are modifiable with directed strategies (obesity, smoking habits, vaccination). Several important steps of assessment and management of asthmatic patients suggested by international guidelines were not fulfilled so we conclude that there is a need to raise awareness to a more precise evaluation of asthmatics in order to achieve a better disease control and avoid severe exacerbations.

  • Asthma - management
  • Exacerbation
  • Quality of life
  • Copyright ©the authors 2016
Previous
Back to top
Vol 48 Issue suppl 60 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Risk for adverse outcomes in asthma: Assess to impress!
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Risk for adverse outcomes in asthma: Assess to impress!
Lilia Maia Santos, Cláudia Chaves Loureiro
European Respiratory Journal Sep 2016, 48 (suppl 60) PA4169; DOI: 10.1183/13993003.congress-2016.PA4169

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Risk for adverse outcomes in asthma: Assess to impress!
Lilia Maia Santos, Cláudia Chaves Loureiro
European Respiratory Journal Sep 2016, 48 (suppl 60) PA4169; DOI: 10.1183/13993003.congress-2016.PA4169
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • X-Tab: Non-interventional study to assess patient-related mid-term outcomes of omalizumab therapy in severe allergic asthmatic patients
  • Prevalence of refractory asthma in population with severe asthma
  • Use of clinical characteristics to predict spirometric classification of obstructive lung disease
Show more 5.2 Monitoring Airway Disease

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society